BioLizard has supported the development of novel biomarker programs, contributed to AI-driven drug discovery efforts, and ...

Innovation is accelerating through bispecifics and dual payload strategies | Emerging ADC development approaches such as ...

Discover how the Impact of R&D on Biotech Companies in India is driving innovation, boosting exports and transforming pharma, ...

The University of Texas recently opened its Innovation Labs, designed to attract private biotech companies and accelerate breakthrough health care research.

Unmatched expertise in patient recruitment and retentionOne of the critical challenges in clinical trials is patient ...

A new report looks at Chinese biotech innovation capturing the attention of pharmaceutical executives and investors worldwide ...

The Industrial Doctoral Landscape and two Doctoral Focal Award programmes – BioProcess, BioAID, and CODE-M – will ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

China’s focus on first or best-in-class oncology drugs and innovative R&D will help it to secure further licensing deals in ...

Unexpected delays, infighting and a staffing crisis are fueling investors’ unease.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.